Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,189
datasets available to search
ShareScore release 0.9.0
Dataset results
2,189 results for “AML”
Study of DT388GMCSF Fusion Protein in Acute Myelogenous Leukemia (AML) and Chronic Myelomonocytic Leukemia (CMML)
ClinicalTrials.gov study NCT00074750. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pilot Evaluation of a Microfluidic Assay to Detect Minimal Residual Disease and Predict Relapse in AML Patients
ClinicalTrials.gov study NCT03488862. IPD Sharing: NO. Countries: 1. Publications: 0.
A Randomized Study of Epigenetic Priming Using Decitabine With Front Line Induction Chemotherapy Compared With Immediate Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects
ClinicalTrials.gov study NCT00943553. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Luveltamab Tazevibulin (STRO-002) in Infants and Children < 12 Years of Age With Relapsed/Refractory CBFA2T3::GLIS2 AML
ClinicalTrials.gov study NCT06679582. IPD Sharing: NO. Countries: 9. Publications: 0.
Study Evaluating the Safety, Tolerability, and Efficacy of FLT3 CAR-T AMG 553 in FLT3-positive Relapsed/Refractory AML
ClinicalTrials.gov study NCT03904069. IPD Sharing: YES. Countries: 1. Publications: 0.
A Study of Bisantrene Combined With Cytarabine or With Decitabine for Adult Subjects With Extramedullary AML and MDS
ClinicalTrials.gov study NCT05456269. IPD Sharing: NO. Countries: 1. Publications: 0.
Azacytidine and Lymphocytes in Relapse of AML or MDS After Allogeneic Stem Cell Transplantation.
ClinicalTrials.gov study NCT02017457. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Assess Change in Disease State in Adult Participants With Acute Myeloid Leukemia (AML) Ineligible for Intensive Chemotherapy Receiving Oral Venetoclax Tablets in Canada
ClinicalTrials.gov study NCT05424562. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
High Dose Donor Hematopoietic Stem Cell Infusion for Relapsed/Refractory AML
ClinicalTrials.gov study NCT03080922. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Study of Crenolanib vs Midostaurin Following Induction Chemotherapy and Consolidation Therapy in Newly Diagnosed FLT3 Mutated AML
ClinicalTrials.gov study NCT03258931. IPD Sharing: NO. Countries: 1. Publications: 0.
Vyxeos Plus Gilteritinib in Relapsed or Refractory, FLT3-Mutated AML
ClinicalTrials.gov study NCT05024552. IPD Sharing: NO. Countries: 1. Publications: 0.
Allo Transplantation With Mylotarg, Fludarabine and Melphalan for AML, CML and MDS
ClinicalTrials.gov study NCT00038831. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Peptide Vaccination in Combination With Azacitidine for Patients With MDS and AML
ClinicalTrials.gov study NCT02750995. IPD Sharing: YES. Countries: 1. Publications: 0.
Efficacy of Venetoclax Based Regimen in Prevention Relapse of Consecutive MRD Positive AML Patients
ClinicalTrials.gov study NCT05361057. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study to Assess the Safety, Tolerability, and Antileukemic Activity of Debio 1562M in Participants With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT06969430. IPD Sharing: NO. Countries: 1. Publications: 0.
Prospective and Retrospective Observational Evaluation of Real World Outcome of Unfit AML Patients Treated With the Combination Venetoclax Plus Hypomethylating Agents, Under the Italian Law No.648/96
ClinicalTrials.gov study NCT04589728. IPD Sharing: Not stated. Countries: 1. Publications: 0.
MAX-40279 in Subjects With Acute Myelogenous Leukemia (AML)
ClinicalTrials.gov study NCT03412292. IPD Sharing: NO. Countries: 1. Publications: 0.
Bioequivalence of Azacitidine 300 mg Film-Coated Tablets in Adult Patients With Acute Myeloid Leukaemia (AML)
ClinicalTrials.gov study NCT06326697. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of the ZN-d5 and ZN-c3 in Subjects With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT05682170. IPD Sharing: NO. Countries: 1. Publications: 0.
PD-1 Inhibitor, Azacitidine and Low-dose DLI in AML Relapse After Allo-HSCT
ClinicalTrials.gov study NCT05772273. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.